GlobalSpace Technologies enters into strategic partnership with Pfizer

18 Feb 2021 Evaluate

GlobalSpace Technologies has entered into strategic partnership with Pfizer, a leading pharmaceutical company for integrating downstream function of providing further value added service in the field of Doctor e-consultation facilitation Tab.

Under this agreement, GlobalSpace group would leverage its Makebot platform for vaccine awareness and DocExa platform for consultation by specialists. As a unique value proposition, Globalspace is also setting up a Virtual Adult Vaccine consultation clinics on Docexa platform. This is one of its kind initiative done in the underserved adult vaccination segment. This platform would also provide a customized booking under Doctor e-consultation Tab which will also be hosted on Pfizer’s consumer microsite.

This Tab will be redirected to an e-consultation page of GlobalSpace which will display relevant doctors who are adult vaccinators (HCPs present on DocExa platform). For this, GlobalSpace will ensure the accuracy of the Data. Pfizer being engaged in the business inter alia of developing, manufacturing and marketing pharmaceutical and consumer healthcare products will help GlobalSpace in expanding its market reach.

GlobalSpace Technologies is a Digital, Mobility, Analytics, AI & Cloud technology company providing integrated healthtech platforms to major stakeholders of Healthcare domain.

Globalspace Tech Share Price

18.98 0.60 (3.26%)
19-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 3163.00
Infosys 1680.35
HCL Tech. 1716.15
Wipro 246.00
Tech Mahindra 1718.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×